We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
-0.26%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$102B
AUM Growth
-$731M
(-0.71%)
Cap. Flow
+$803M
Cap. Flow
% of AUM
0.79%
Top 10 Holdings %
Top 10 Hldgs %
35.47%
Holding
263
New
6
Increased
107
Reduced
91
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
JPMorgan Chase
JPM
|
+$285M |
| 3 |
NetApp
NTAP
|
+$279M |
| 4 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$225M |
| 5 |
HP
HPQ
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$585M |
| 2 |
CME Group
CME
|
+$258M |
| 3 |
Honeywell
HON
|
+$194M |
| 4 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$131M |
| 5 |
Intuit
INTU
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.73% |
| 2 | Technology | 26.95% |
| 3 | Industrials | 13.34% |
| 4 | Consumer Discretionary | 8.18% |
| 5 | Financials | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biogen
BIIB
$29.6B
| $6.67B | 6.56% |
16,501,541
-57,222
| -0.3% | -$23M |
|
2
Eli Lilly
LLY
$1.06T
| $5.01B | 4.93% |
60,059,630
+610,736
| +1% | +$46.5M |
|
3
Amgen
AMGN
$201B
| $4.81B | 4.73% |
31,351,688
-136,322
| -0.4% | -$21.8M |
|
4
Adobe
ADBE
$84.3B
| $2.97B | 2.92% |
36,683,855
-119,211
| -0.3% | -$9.3M |
|
5
Texas Instruments
TXN
$260B
| $2.95B | 2.9% |
57,276,849
-133,622
| -0.2% | -$7.37M |
|
6
Alphabet (Google) Class C
GOOG
$3.89T
| $2.85B | 2.81% |
107,563,080
-261,321
| -0.2% | -$7M |
|
7
Microsoft
MSFT
$2.83T
| $2.77B | 2.73% |
62,824,927
-78,896
| -0.1% | -$3.6M |
|
8
FedEx
FDX
$74.7B
| $2.58B | 2.54% |
15,157,346
-32,427
| -0.2% | -$5.64M |
|
9
Southwest Airlines
LUV
$21.9B
| $2.57B | 2.53% |
77,813,973
+202,983
| +0.3% | +$7.94M |
|
10
Novartis
NVS
$297B
| $2.18B | 2.14% |
24,705,850
-43,250
| -0.2% | -$3.97M |
|
|
SCHW
11
Charles Schwab
SCHW
$177B
| $1.98B | 1.95% |
60,570,527
-346,941
| -0.6% | -$11M |
|
12
Bath & Body Works
BBWI
$3.9B
| $1.83B | 1.8% |
26,375,112
+206,674
| +0.8% | +$14.8M |
|
|
MON
13
DELISTED
Monsanto Co
MON
| $1.33B | 1.31% |
12,486,877
-35,505
| -0.3% | -$4.12M |
|
14
Sony
SONY
$122B
| $1.3B | 1.28% |
228,831,250
-148,175
| -0.1% | -$908K |
|
|
15
HP
HPQ
$22.4B
| $1.27B | 1.25% |
93,476,624
+9,566,761
| +11% | +$142M |
|
|
16
NetApp
NTAP
$32.3B
| $1.24B | 1.22% |
39,185,758
+8,056,571
| +26% | +$279M |
|
17
Medtronic
MDT
$105B
| $1.21B | 1.2% |
16,396,096
-1,149,125
| -7% | -$87.8M |
|
18
Carnival Corporation Ltd
CCL
$34.6B
| $1.18B | 1.16% |
23,919,580
+157,470
| +0.7% | +$7.43M |
|
|
DTV
19
DELISTED
DIRECTV COM STK (DE)
DTV
| $1.16B | 1.14% |
12,457,523
-1,446,450
| -10% | -$131M |
|
20
Johnson & Johnson
JNJ
$624B
| $1.11B | 1.09% |
11,370,350
-488,527
| -4% | -$48.9M |
|
21
BioMarin Pharmaceuticals
BMRN
$11.4B
| $1.09B | 1.08% |
7,992,749
-32,259
| -0.4% | -$4M |
|
22
United Airlines
UAL
$37.4B
| $1.08B | 1.06% |
20,378,085
+487,214
| +2% | +$28.2M |
|
|
MRSH
23
Marsh
MRSH
$84.2B
| $1.07B | 1.06% |
18,950,551
-1,526,513
| -7% | -$88.2M |
|
24
Qualcomm
QCOM
$180B
| $1.06B | 1.05% |
16,994,435
+1,546,755
| +10% | +$106M |
|
25
Intel
INTC
$504B
| $980M | 0.96% |
32,232,335
-98,433
| -0.3% | -$3.18M |
|
Similar funds
Primecap Management's Q2 2015 Portfolio in Review
As of Q2 2015, Primecap Management held 263 positions worth $102B, down 0.71% from $102B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q2 2015: portfolio turnover was 3.4%. Primecap Management opened 6 new positions and exited 3, leaving the 263-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.
- Primecap Management's largest Q2 2015 buy was Pfenex Inc.: 2,371,388 shares worth $46M.
- Primecap Management added most to Alibaba in Q2 2015, an estimated $347M increase.
- Primecap Management's biggest Q2 2015 reduction was CME Group, cutting an estimated $258M.
- Primecap Management fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $585M.
- Primecap Management's ten largest holdings make up 35% of its $102B portfolio in Q2 2015.
- Primecap Management opened 6 new positions and closed 3 in Q2 2015.
- Primecap Management's portfolio value fell 0.71% quarter-over-quarter to $102B.
Based on Primecap Management's 13F filing for Q2 2015, filed 13 Aug 2015.